Indivior has planned to cancel the secondary listing of the firm’s shares on the London Stock Exchange. In a notice today (2 ...

Drug maker Indivior (INDV.L) has announced plans to delist its shares from the London Stock Exchange (LSE), marking the ...

Drugmaker Indivior has announced plans to cancel its secondary listing in London, just a year after moving its primary ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

As it works to send opioid use disorder (OUD) treatment Sublocade back into its prior growth territory, Indivior is switching ...

Drug maker Indivior has announced plans to delist its shares from the London Stock Exchange (LSE), marking the latest company ...

Indivior is set to delist from the London Stock Exchange after a sharp decline in the value of its shares and a management ...

The British pharmaceuticals company said the US exchange offers the ‘most attractive and valuable opportunity set’ ...

Pharmaceutical firm Indivior has announced it will soon delist from the London Stock Exchange, keeping its primary listing on ...